Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02854033 · ClinicalTrials.gov registry record
Alzheimer's Disease Neuroimaging Initiative 3
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 1,141
- Enrollment target
NCT02854033 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 1,141 participants.
The verdict
NCT02854033 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 1,141 participants
- Enrollment target
Study Summary
Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD. ADNI3 continues the previously funded ADNI-1, ADNI-GO, and ADNI-2 studies that have been combined public/private collaborations between academia and industry to determine the relationships between the clinical, cognitive, imaging, genetic and biochemical biomarker characteristics of the entire spectrum of Alzheimer's disease (AD). The overall goal of the study is to continue to discover, optimize, standardize, and validate clinical trial measures and biomarkers used in AD research.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,141 participants |
| Start Date | 2016-12-02 |
| Est. Completion | 2024-05-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02854033
The ClinicalTrials.gov registry entry for NCT02854033 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02854033 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02854033 about?
NCT02854033 is a clinical study titled "Alzheimer's Disease Neuroimaging Initiative 3". Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD. ADNI3 continues the previously funded ADNI-1, ADNI-GO, and ADNI-2 studies that have been combined public/private collaboratio...
What is the current status of trial NCT02854033?
This trial is currently completed. The enrollment target is 1,141 participants. The study started on 2016-12-02. Estimated completion is 2024-05-28.
Who is sponsoring clinical trial NCT02854033?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.